Clinical trial
Effectiveness of Protected Environment Rooms for AML and MDS
NCT00443300 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00443300 |
|---|---|
| Title | Effectiveness of Protected Environment Rooms for AML and MDS |
| Official title | Effectiveness of HEPA-filtered Rooms ("Protected Environment") to Prevent Morbidity and Mortality in Patients Age >/ = 60 Receiving Lower Intensity ("Targeted") Therapy for Untreated AML and High-risk Myelodysplasia (MDS) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Acute Myelogenous Leukemia, Myelodysplastic Syndrome |
| Enrollment | 3 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Mar 5, 2007 |
| Last update posted | Aug 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: